Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-010624
Filing Date
2023-03-29
Accepted
2023-03-29 16:22:00
Documents
5
Effectiveness Date
2023-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 2023_s-8_evergreen.htm S-8 244467
2 EX-5.1 bolt-ex5_1.htm EX-5 20859
3 EX-23.1 bolt-ex23_1.htm EX-23 2819
4 EX-FILING FEES bolt-exfiling_fees.htm EX-FILING FEES 57052
5 GRAPHIC img38739919_0.jpg GRAPHIC 2122
  Complete submission text file 0000950170-23-010624.txt   329347
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270938 | Film No.: 23775513
SIC: 2834 Pharmaceutical Preparations